Early Intervention in Localized Wegener’s Granulomatosis With Sensorineural Hearing Loss Preserves Hearing Purpose Wegener’s granulomatosis has been renamed granulomatosis with polyangiitis (GPA). In this article, the authors refer to WG as “WG/GPA” to indicate the old and new names of this condition. WG/GPA is a systemic necrotizing granulomatous vasculitis that can affect, in particular, the lungs, sinuses, and kidneys. The authors report ... Clinical Focus
Clinical Focus  |   December 01, 2012
Early Intervention in Localized Wegener’s Granulomatosis With Sensorineural Hearing Loss Preserves Hearing
 
Author Affiliations & Notes
  • Vasuky Sriskandarajah
    Epsom and St. Helier University Hospitals National Health Service Trust, Carshalton, England
  • Rhea A. Bansal
    Epsom and St. Helier University Hospitals National Health Service Trust, Carshalton, England
  • Robin Yeoh
    Epsom and St. Helier University Hospitals National Health Service Trust, Carshalton, England
  • Amolak S. Bansal
    Epsom and St. Helier University Hospitals National Health Service Trust, Carshalton, England
  • Correspondence to Amolak S. Bansal: Amolak.Bansal@esth.nhs.uk
  • Editor and Associate Editor: Larry Humes
    Editor and Associate Editor: Larry Humes×
Article Information
Hearing Disorders / Clinical Focus
Clinical Focus   |   December 01, 2012
Early Intervention in Localized Wegener’s Granulomatosis With Sensorineural Hearing Loss Preserves Hearing
American Journal of Audiology, December 2012, Vol. 21, 121-126. doi:10.1044/1059-0889(2012/12-0003)
History: Received January 16, 2012 , Revised May 16, 2012 , Accepted May 20, 2012
 
American Journal of Audiology, December 2012, Vol. 21, 121-126. doi:10.1044/1059-0889(2012/12-0003)
History: Received January 16, 2012; Revised May 16, 2012; Accepted May 20, 2012
Web of Science® Times Cited: 4

Purpose Wegener’s granulomatosis has been renamed granulomatosis with polyangiitis (GPA). In this article, the authors refer to WG as “WG/GPA” to indicate the old and new names of this condition. WG/GPA is a systemic necrotizing granulomatous vasculitis that can affect, in particular, the lungs, sinuses, and kidneys. The authors report 2 cases with antineutrophil cytoplasmic antibodies (c-ANCA) positive WG/GPA whose initial presentations were in the form of both conductive and sensorineural hearing loss without systemic features. The authors contrast the reversal of hearing loss and prevention of disease progression with early recognition and treatment.

Method The authors present 2 contrasting cases of WG/GPA. Changes in hearing were measured through use of a GSI 61 audiometer as well as guidelines from the British Society of Audiology. Serum ANCA were detected by indirect immunofluorescence and formalin fixed neutrophils. Proteinase 3 (PR3) and myeloperoxidase antibodies were measured through use of a fluoroenzyme immunoassay.

Results Persistent deafness and systemic disease are more likely, and more aggressive therapy was required when the diagnosis of WG/GPA was delayed.

Conclusion WG/GPA should be considered in acute or subacute deafness presenting over days to weeks and even in the absence of systemic symptoms. A negative or weak ANCA with absent antibodies to serine PR3 and myeloperoxidase should not exclude the possible diagnosis of WG/GPA, and a high index of suspicion should be maintained.

Order a Subscription
Pay Per View
Entire American Journal of Audiology content & archive
24-hour access
This Article
24-hour access